Increased Expression of Histone Deacetylase 2 is Found in Human Hepatocellular Carcinoma |
Noh, Ji-Heon
(Lab of Pathology, College of Medicine The Catholic University of Korea)
Eun, Jung-Woo (Lab of Pathology, College of Medicine The Catholic University of Korea) Ryu, So-Yeon (Lab of Pathology, College of Medicine The Catholic University of Korea) Jeong, Kwang-Wha (Lab of Pathology, College of Medicine The Catholic University of Korea) Kim, Jung-Kyu (Lab of Pathology, College of Medicine The Catholic University of Korea) Lee, Sug-Hyung (Lab of Pathology, College of Medicine The Catholic University of Korea) Park, Won-Sang (Lab of Pathology, College of Medicine The Catholic University of Korea) Yoo, Nam-Jin (Lab of Pathology, College of Medicine The Catholic University of Korea) Lee, Jung-Young (Lab of Pathology, College of Medicine The Catholic University of Korea) Nam, Suk-Woo (Lab of Pathology, College of Medicine The Catholic University of Korea) |
1 | Kinzler, K.W. & Vogelstein, B. Life (and death) in a malignant tumour. Nature 379, 19-20 (1996) DOI ScienceOn |
2 | Pang, A., Ng, I.O., Fan, S.T. & Kwong, Y.L. Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 146, 8-15 (2003) DOI ScienceOn |
3 | Ballestar, E. & Esteller, M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23, 1103-1109 (2002) DOI ScienceOn |
4 | Gui, C.Y. et al. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter- associated proteins, including HDAC1. Proc Natl Acad Sci USA 101, 1241-1246 Epub 2004 Jan 20 (2004) |
5 | Villar-Garea, A. & Esteller, M. Histone deacetylase inhibitors: Understanding a new wave of anticancer agents. Int J Cancer 112, 171-178 (2004) DOI ScienceOn |
6 | Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990) DOI ScienceOn |
7 | Imai, S., Armstrong, C.M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800 (2000) DOI ScienceOn |
8 | Park, W.S. et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119, 691-698 (2000) DOI ScienceOn |
9 | Frye, R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 273, 793-798 (2000) DOI ScienceOn |
10 | Zhu, P. et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463(2004) DOI ScienceOn |
11 | Park, W.S. et al. Inactivating mutations of the caspase- 10 gene in gastric cancer. Oncogene 21, 2919- 2925 (2002) DOI ScienceOn |
12 | Marks, P.A., Richon, V.M. & Rifkind, R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst. 92, 1210-1216 (2000) DOI ScienceOn |
13 | Weidle, U.H. & Grossmann, A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res. 20, 1471-1485 (2000) |
14 | Clements, W.M. et al. Beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62, 3503-3506 (2002) |
15 | Parkin, D.M., Pisani, P. & Ferlay, J. Global cancer statistics. CA Cancer J Clin. 49, 33-64 (1999). DOI ScienceOn |
16 | de La Coste, A. et al. Somatic mutations of the betacatenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95, 8847-8851 (1998) |
17 | Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 24, 245-250 (2000) DOI ScienceOn |
18 | Yang, W.M. et al. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem. 272, 28001-28007 (1997) DOI ScienceOn |
19 | Schafer, D.F. & Sorrell, M.F. Hepatocellular carcinoma. Lancet 353, 1253-1257 (1999) DOI ScienceOn |